June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Complement dysregulation in an iPSC-RPE model with CFH/FHL-1 haploinsufficiency.
Author Affiliations & Notes
  • Rayne Lim
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Sharlene Shirali
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Jessica Rowlan
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Abbi Engel
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Marcos Nazario
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Jianhai Du
    Ophthalmology and Visual Sciences, West Virginia University, Morgantown, West Virginia, United States
    Biochemistry, West Virginia University, Morgantown, West Virginia, United States
  • Maureen Neitz
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Jay Neitz
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Jennifer R Chao
    Ophthalmology, University of Washington, Seattle, Washington, United States
  • Footnotes
    Commercial Relationships   Rayne Lim None; Sharlene Shirali None; Jessica Rowlan None; Abbi Engel None; Marcos Nazario None; Jianhai Du None; Maureen Neitz None; Jay Neitz None; Jennifer Chao None
  • Footnotes
    Support  NIH Grant EY026030, NEI Vision Research Core EY001730, Alcon Research Institute, BrightFocus Foundation M2020217, Research to Prevent Blindness Sybil B. Harrington Physician-Scientist Award for Macular Degeneration, Research to Prevent Blindness Unrestricted Grant
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1473. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rayne Lim, Sharlene Shirali, Jessica Rowlan, Abbi Engel, Marcos Nazario, Jianhai Du, Maureen Neitz, Jay Neitz, Jennifer R Chao; Complement dysregulation in an iPSC-RPE model with CFH/FHL-1 haploinsufficiency.. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1473.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Early onset macular drusen (EOMD) is an inherited retinal degeneration where patients develop clinical features similar to AMD early in life. This rare condition is associated with high penetrance genetic variants in the complement factor H (CFH) gene which result in loss of CFH and factor H-like protein 1 (FHL-1) expression. We identified an EOMD family with a novel c.351-2A>G variant in the conserved 3’ splice site of exon 4. Induced pluripotent stem cells (iPSC)-derived retinal pigment epithelium (RPE) generated from two EOMD patients heterozygous for the mutation showed significantly reduced (~ 50%) CFH and FHL-1 expression, consistent with haploinsufficiency. This study will examine the effects of CFH/FHL-1 haploinsufficiency on complement inhibition and regulators of complement activators (RCA) in RPE.

Methods : iPSC-RPE derived from healthy controls and EOMD subjects were seeded on Matrigel coated dishes and transwell filters. Media CFH/FHL-1 levels were quantified by WB and ELISA, and an in situ C3b breakdown was performed to assay CFH/FHL-1 function. Expression of soluble complement components were evaluated via real-time PCR and WB. Expression of RCA members were also assessed with real-time PCR and immunostaining. RPE cultured on chamber slides were treated with 10% NHS and stained for C5b-9 to visualize MAC deposition.

Results : EOMD RPE cells had a significantly decreased CFH protein secretion per cell and reduced in situ C3b cleavage activity. In naïve conditions, EOMD RPE had elevated levels of soluble C3bα, C3bβ, and C3bα fragments, consistent with higher C3 turnover. No differences in C5 and CFI protein expression was found. Transcript levels of CD46 (membrane cofactor protein; MCP), CD55 (decay accelerating factor; DAF) and clusterin (CLU) were unchanged, while CD59 and vitronectin (VTN) were significantly increased. On immunostaining, VTN and CLU-positive deposits were found only in EOMD RPE and increased basal localization of CD55 was observed. In response to treatment with 10% NHS, MAC deposition was significantly increased in EOMD RPE compared to controls.

Conclusions : These findings indicate that reduction in CFH and FHL-1 expression contributes to complement dysregulation, suggesting that the RPE cells derived from EOMD patients could be more susceptible to complement-mediated stress.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×